RE:Podcast on Viemed:LongTerm3 really great find, thanks for sharing. If you are a current shareholder, or potential investor this is a must watch video podcast. It is an hour long, but so full of valuable and head scratching information.
As mentioned, the runway is massive for this little company. The repeat message that these guys kept hammering on was the mind boggling fact that Viemed has grown year over year at 30 to 40% organically, and is only trading at 15 times free cash flow. Obviously in their view, the stock should be trading much higher.
The mid term target price mentioned was $18.00 U.S. Today that is roughly what, around $23 Canuck bucks, who wouldn't take that share price down the road. GLTA